Transgender Health Group Labels Its Care Standards as Mere Opinions in Court Filing

The World Professional Association for Transgender Health (WPATH) submitted a motion asserting that its widely-cited Standards of Care should be viewed as opinion-based guidance, not binding medical doctrine. This admission comes as the Federal Trade Commission, together with Texas, Alaska, Iowa and Nebraska, sues the group for allegedly enabling providers to obtain insurance coverage for gender-affirming treatments through deceptive claims of medical necessity.

Opponents, such as the Society for Evidence-Based Gender Medicine, argue that WPATH has historically presented its guidelines as the definitive standard, pressuring mainstream medical bodies to adopt them. The lawsuit also highlights instances where institutions have used questionable diagnoses like “Endocrine Disorder” to secure coverage, a practice encouraged by WPATH’s 2024 guidance. In response, WPATH’s counsel claims the plaintiffs seek to censor one half of a scientific debate and overstep federal authority, citing recent Supreme Court rulings on related issues. Commentators like Jared Ross and Leor Sapir view the filing as a possible retreat by WPATH amid growing scrutiny of its role in transgender healthcare policy.